Skip to main content
Livermore
Livermore
ZHEN

Euclidean Capital LLC

SEC CIK
0001825034
Latest filing
Aug 14, 2026

PMVP holding history

PMV Pharmaceuticals, Inc. in every 13F filed by Euclidean Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PMVP overviewAll 13F holders of PMVPFull Q2 2026 holdings

Shares (Q2 2026)
2,627,643
Value
$3.52M
% of portfolio
0.8%
Quarters held
22
Since Q1 2021
Holdings of PMVP by Euclidean Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,627,643$3.52M0.8%00.0%UnchangedHolders
Q1 20262,627,643$3.26M0.8%00.0%UnchangedHolders
Q4 20252,627,643$3.28M0.9%00.0%UnchangedHolders
Q3 20252,627,643$3.68M1.5%00.0%UnchangedHolders
Q2 20252,627,643$2.79M0.9%00.0%UnchangedHolders
Q1 20252,627,643$2.86M1.1%00.0%UnchangedHolders
Q4 20242,627,643$3.97M0.5%00.0%UnchangedHolders
Q3 20242,627,643$3.92M0.4%00.0%UnchangedHolders
Q2 20242,627,643$4.26M0.5%00.0%UnchangedHolders
Q1 20242,627,643$4.47M0.6%00.0%UnchangedHolders
Q4 20232,627,643$8.15M0.9%00.0%UnchangedHolders
Q3 20232,627,643$16.1M3.5%+82,401+3.2%AddedHolders
Q2 20232,545,242$15.9M4.1%+208,333+8.9%AddedHolders
Q1 20232,336,909$11.1M9.8%00.0%UnchangedHolders
Q4 20222,336,909$20.3M19.0%00.0%UnchangedHolders
Q3 20222,336,909$27.8M25.8%00.0%UnchangedHolders
Q2 20222,336,909$33.3M28.3%00.0%UnchangedHolders
Q1 20222,336,909$48.7M28.3%00.0%UnchangedHolders
Q4 20212,336,909$54.0M30.7%−432,904−15.6%ReducedHolders
Q3 20212,769,813$82.5M40.1%−1,138,864−29.1%ReducedHolders
Q2 20213,908,677$133.5M43.3%−270,739−6.5%ReducedHolders
Q1 20214,179,416$137.5M46.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.